the new antiarrhythmic drug propafenone and its main human metabolite 5-hydroxypropafenone were investigated for antiarrhythmic , local anaesthetic , ca++-antagonistic and beta-adrenoceptor blocking effects as well as for their activity on the central nervous system .
C0003195
antiarrhythmic drug
C0033429
propafenone